Navigation Links
Bergman in Medical News

Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics

... Catalyst Biosciences, Inc. Erik Wiberg +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Anixter Center Announces Leadership Changes

... Current President and CEO bergman to depart effective July 3; Board member Krema to ...ter Center president and CEO, announced today that bergman will step down from his position, effective July 3. bergman has served in this role since his appointment foll...

Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products

... Petkus +1.650.266.8654 +1.973.660.5218 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO

... Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Spotlight 29 Casino Laughs It Up With Rita Rudner

...'d never fallen in love. I'd stepped in it a few times. When I eventually met Mr. Right I had no idea that his first name was Always." Rudner and bergman spend their time between their homes in Las Vegas and southern California. "In Hollywood a marriage is a success if it outlasts milk," Rudner has said...

Annual medical ethics conference celebrates 20 years of disputes

...f clinical medical ethics, improved end-of-life care for patients, and new ethical approaches to innovations in surgical can cancer care. The Lindy bergman Distinguished Service Professor of Medicine at the University, Siegler has written and spoken extensively on decision-making in complex medical situat...

Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer

...ences, Inc. Erik Wiberg Chief Financial Officer +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show

...rk that will only be seen during the two days of the fundraising event. All talent in the show donates their time. Sponsors include Paris Las Vegas, bergman Walls & Associates, The Boughner Family Foundation, Century 21 MoneyWorld, David Greenhouse Photography/Liquid Light Studios, Findlay Cadillac Saab, H...

Smile! Make Your New Year's Resolutions a Reality This Year

...ww.pg.com for the latest news and in-depth information about P&G and its brands. For more information: Taryn Levy Kerri bergman 212-891-0404 212-891-0450 tlevy@devries-pr.com kbergman@devries-pr.com ...

Parents: With Halloween Candy, Focus on Choice and Time to Prevent Teeth Decay

... Washington Dental Service website at http://www.DeltaDentalWA.com . Contacts: Sean Pickard (206) 528-2304 spickard@deltadentalwa.com or Paul bergman (206) 528-7346 pbergman@deltadentalwa.com ...
Bergman in Medical Technology

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

...ct information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development & Chief ...

Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting

... information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and Corporate 650-575-1509 or 415-794-8662 ...

Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting

...tact information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development & Chief ...

Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology

... Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia

...com . Catalyst Biosciences, Inc. Erik Wiberg +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...
Bergman in Biological News

New technique used to profile anthrax genome

... RNA-Seq to any bacterium. In using this approach to study B. anthracis, bergman and colleagues sequenced mRNA samples that were collected from B. anthracis...onal approach to tasks like antibiotic discovery and microbial engineering, bergman noted. "Sequencing-based transcriptome profiling has several huge adva...

Hebrew University scientists reveal mechanism that triggers differentiation of embryo cells

...uctural and Molecular Biology , Professors Yehudit bergman and Howard Cedar of the Hebrew University-Hadassah...lls that can differentiate into specific tissues. bergman is the Morley Goldblatt Professor of Cancer Resear.... Now, with the new information discovered by bergman and Cedar, the molecular program that is responsib...
Bergman in Biological Technology

Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association

...tact information Media Inquiries: All Other Inquiries: BCC Partners Craig C. Parker Karen L. bergman or Michelle Corral Senior Vice President, Finance and 650-575-1509 or 415-794-8662 Corporate Development ...

Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team

... Media Inquiries: Craig C. Parker BCC Partners Senior Vice President, Finance and Karen L. bergman or Michelle Corral Corporate Development & Chief 650-575-1509 or 415-794-8662 Financial Officer 650-266-2682 ...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

... Erik Wiberg Chief Financial Officer +1.650.266.8654 ewiberg@catbio.com BCC Partners for Catalyst Biosciences, Inc. Karen L. bergman or Michelle Corral +1.650.575.1509 or +1.415.794.8662 ...

Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology

... information Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology

...stors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Orange and Medic4all Launched the World's First Cellular Tele-Health Service

...ttp://www.medic4all.com ) is based in Switzerland and has activities in 28 countries in the world. For further information, please contact Mr. David bergman at info@medic4all.com, +972-3-9226610 ...

Proteolix Raises $79 Million in Series C Financing

...ormation Investors: Media Inquiries: Matthew Ferguson BCC Partners Chief Financial Officer Karen L. bergman or Michelle Corral 650-266-2825 650-575-1509 or 415-794-8662 investors@proteolix.com ...

Taming the anthrax threat

... immune cells able to kill most bacteria. Somehow the bacterium avoids being killed and actually hijacks these phagocytes (microbe-killing cells), bergman says. New drugs, he says, should target the bug during the brief window of vulnerability when the bacteria transform from dormant spores into active, ...

Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden

...le to pay taxes and other debts. The bankruptcy court has appointed Anders bergman of Ackordscentralen Norrland AB as bankruptcy administrator for ViraNative....ess their orderly liquidation and sale in accordance with Swedish laws. Mr. bergman can be reached by telephone at: +46 (0) 90-70 62 00; and by email at: ande...

Taming the anthrax threat

... immune cells able to kill most bacteria. Somehow the bacterium avoids being killed and actually hijacks these phagocytes (microbe-killing cells), bergman says. New drugs, he says, should target the bug during the brief window of vulnerability when the bacteria transform from dormant spores into active, ...
Other Tags
(Date:7/13/2014)... July 13, 2014 A Massachusetts couple ... the cancer risks associated with power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ... story to federal regulators, as they presented poignant testimony ... & Drug Administration (FDA) advisory panel meeting convened to ... to the Rochester Democrat and Chronicle, Dr. Hooman Noorchashm ...
(Date:7/13/2014)... York, New York (PRWEB) July 13, 2014 ... lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against Johnson ... litigation’s second bellwether trial, which is expected to get ... Order issued in the U.S. District Court, Southern District ... Conference will be held on August 7, 2014 at ...
(Date:7/13/2014)... Fadhits.com is popular among worldwide women. ... extremely beautiful. Recently, the company has announced its new ... What’s more, all these outfits are available at discounted ... Additionally, the supplier is now offering similar discounts for ... it has many other designs for sale, including flower ...
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently updated ... what to do to eliminate the root cause of ... review that readers can easily learn what foods to avoid ... Vkool also informs in its Kidney Disease Solution review that ... naturally. The book consists of a collection of natural remedies ...
(Date:7/13/2014)... Seattle, WA (PRWEB) July 13, 2014 ... Ken Woolcott, who commented, “As a parent of a ... the underserved need in the Seattle community for contemporary ... will provide an important alternative to students and families ... the best practices and environment for special education. We ...
Breaking Medicine News(10 mins):Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2
(Date:7/11/2014)... SEATTLE, WASH. July 11, 2014 Researchers ... navigate three-dimensional images. The new technology, called Virtual ... of small structures like neurons and synapses using ... Finger,s unique technology makes 3D imaging studies orders ... resources at an unprecedented level across many areas ...
(Date:7/11/2014)... the marginal division of the striatum is also ... impact degree of substance P in the striatal ... Yu and his team, College of Biophotonics, South ... that substance P receptor, neurokinin 1 was highly ... of normal rats. Unilateral or bilateral injection of ...
(Date:7/11/2014)... Research and Markets has announced ... - Industry Analysis Size Share Growth Trends and Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 The rising ... need for high level security in both private and ... as username and passwords, tokens etc. are vulnerable to ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
Other Contents